According to Merus's latest financial reports and stock price the company's current Operating Margin is -135.57%. At the end of 2021 the company had an Operating Margin of -135.58%.
Year | Operating Margin | Change |
---|---|---|
2021 | -135.58% | -52.25% |
2020 | -283.91% | 60.83% |
2019 | -176.52% | 130.7% |
2018 | -76.52% | -86.97% |
2017 | -587.18% | -83.44% |
2016 | -3,545.65% | 101.11% |
2015 | -1,763.04% | -21.31% |
2014 | -2,240.54% | -57.26% |
2013 | -5,242.33% |
Company | Operating Margin | Operating Margin differencediff. | Country |
---|---|---|---|
ORIC Pharmaceuticals
ORIC | 0.00% | N/A | ๐บ๐ธ USA |
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.